Therapeutic response and side effects of repeated radioligand therapy with 177Lu- PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer

Autor:	Ahmadzadehfar, H., Eppard, E., Kürpig, S., Fimmers, R., Yordanova, A., Schlenkhoff, C.D., Rogenhofer, S., Essler, M.
Jazyk:	angličtina
Rok vydání:	2016
Předmět:	ddc: 610 610 Medical sciences Medicine urologic and male genital diseases
Zdroj:	62. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie; 20160414-20160415; Münster; DOCV4.6 /20160225/
Popis:	Introduction: Prostate-specific membrane antigen (PSMA) is highly expressed on prostate epithelial cells and strongly up-regulated in prostate cancer, making it an optimal target for the treatment of metastasized prostate cancers. Radioligand therapy (RLT) with 177Lu- PSMA-DKFZ-617 (Lu-PSMA) is a novel[for full text, please go to the a.m. URL] 62. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0dc01c48d2366a596dd3701a4f09308 http://nbn-resolving.de/urn:nbn:de:0183-16nrwgu517 Zobrazit plný text záznamu